|
1) How to increase your
suicide risk…
If you are elderly and have
certain chronic diseases such as bipolar disease, depression,
COPD, …. you are more likely to attempt suicide. The authors
link the diseases to suicide. Being a pharmacist, I think more
about the drugs used in these diseases as the potential
"cause". Antidepressants "activate" severely depressed patients
who wanted to commit suicide but could not muster the effort.
Many drugs used against high blood pressure and heart failure
are notorious for causing chemical imbalances that manifest as
depression. Drugs used urinary incontinence can cause "atropine
psychosis" and other psychiatric symptoms. I'd say it may be
more than a coincidence that these people saw a physician within
a week of attempting to harm themselves. (but then again I only
edit the ppp instead of the Archives of Internal Medicine)
Original paper is
Arch
Intern Med
2004;164:1171-1172,1179-1184.
http://www.medscape.com/viewarticle/480964?src=mp
2)
Testimony on safety of imports…
Only 1 in 10 packages
inspected. Misbranded, mislabeled, and fake drugs found.
http://www.medscape.com/viewarticle/481253?src=mp
3)
Stupak stews about Accutane.
After the death of his son
by suicide while taking Accutane the congressman has pursued
this issue. This illustrates the difficulty that manufacturers
encounter when trying to attribute "side effects" to drugs…. For
example: If a patient already had a cancer but never been
diagnosed with cancer and, after exposure to a drug subsequently
the cancer was diagnosed with cancer then the drug gets blamed.
A single case does not prove
the association and is the reason that the FDA insists upon
multipatient tests prior to approval and robust post-marketing
scrutiny. Accutane (and the generics now available after the 20
year patent expired) already has enhanced warning labels and is
under one of the tightest medication controls available. (it is
easier to obtain narcotics!). The FDA continues to investigate
how to regulate and make this drug safer.
http://www.detnews.com/2004/health/0406/16/politics-185803.htm
4)
National drug trend moderated by generic use.
Release of a study done by a
PBM shows a 7.9% increase in per prescription prices. (Last year
it was about double that rate). The ethical pharmaceutical
companies are feeling the pressure but they knew when their
patents would expire when they started manufacturing and selling
the brand names. I wonder if they have extracted the cost of
development and a little profit along the way…. If they find
themselves surprised by patent loss then they had better assign
someone in marketing who can read a calendar.
http://www.newswise.com/p/articles/view/505423/
|